Owaves, Inc. is a health technology and media company revolutionizing time around health and well-being. Ranked #1 for keyword "wellness" in the App Store, Owaves produces chronotherapeutic software integrating IoT and machine learning to optimize circadian rhythm. Owaves is based in Encinitas, CA and was founded in May of 2013.

Capitalization, Innovation, commercialization, strategy advisor to VCs, PE firms, CEOs, Founders in the medtech, digital health, virtual connected patient care and wellness industry.

EvoNexus is dedicated to helping startups, particularly those admitted into the EvoNexus incubator program. Our Committee assists in recruiting, vetting, and mentoring EvoNexus companies. MarketLink connects tech industry giants with emerging technology companies across the globe.

Cohero Health is a digital therapeutics company developing innovative connected technologies and services to improve patient outcomes in respiratory care, reduce avoidable costs, and improve medication adherence.Our comprehensive suite of tools and technology comprises form flexible smart inhaler sensors and mobile spirometers to track real-time adherence & lung function, and a highly engaging mobile application accessible on iPhone, iWatch, and Android. Based in New York City, the company is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech. The company’s platform has been used by pulmonary patients in over 25 commercial deployments, reaching over 1 million covered lives. Cohero Health is backed by Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts; Three Leaf Ventures, an affiliate of the Broe Group; BioAdvance; Heitkamp & Thumann Group; Samsung NEXT; Omron Healthcare; GIS Strategic Ventures; and P5 Health Ventures.

Smart point-of-care mobile solution for clinical workflow, unified communications, and care coordination. Through safety improvements, increased productivity, workforce engagement, and EMR optimization, the PatientTouch solution drives enhanced clinical and financial performance in the hospital environment. Positioned the business and product strategy to address digital health markets. Architected company’s business model to tech-enabled cloud software services over a smart point of care mobile handheld device network for clinical workflow, patient safety, secure alerting and communication, and care coordination.Raised $35M in strategic and growth capital from leading firms Merck, Psilos, TPG, Camden Partners, Singapore EDBi, and TELUS Ventures. Secured a $15M non-dilutive debt instrument and LOC to accelerate operational and R&D initiatives. Created +$100M in shareholder value in 4 years.Staffed and mentored senior team. Built the internal infrastructure to support objectives of growth, sales process and technology delivery models that improved demand generation and time to revenue recognition.Negotiated and closed $20M TCV agreement with nationally recognized NewYork-Presbyterian. Led the company into a mobile innovation collaborative with HCA. Signed commercial sale and innovation agreement with renowned Hoag Orthopedic Institute for enterprise wide mobile clinical communications.Grew GAAP revenue from $1M to $16M, recurring revenue to $5M and committed contracts to $24M with 58% margins. Significant reduction in net operating loss. Engineered a new SaaS based revenue model.Launched company’s APAC initiative in Singapore with manufacturing operations and sales development. Acquired Vree Health from Merck in a stock and cash transaction in October 2015 and integrated the business, providing the first-of-its-kind technology enabled service for care coordination-positioned the company for expansion into the $12B emerging market.

CareFusion (CFN) a public spin-off from Cardinal Health. Management created a $4.5B multi-faceted Medtech global leader with business lines in Infusion, Respiratory, Medication Dispensing, Mobile Technology, Enterprise Software, Informatics and Device Connectivity. Established CareFusion wireless health strategy and global ecosystem and HIT alliances and clinical informatics investment and licensing.

Operations, M&A, Business Development, Strategy & Innovation. Technology and portfolio management. Intellectual Property (IP) licensing.Led aggressive investment in innovation, and acquisition of complementary companies and technologies. GM for operations and integration of CareFusion, Inc. mobility solutions and wireless enterprise clinical information technology.Executive leader on global strategic alliances and healthcare IT connectivity solutions architect for $2B (Alaris Medical Systems and Pyxis Automation) global portfolio assets of CareFusion.Innovation and new business development for wireless medicine programs and partnerships. Establishing key relationships with West Wireless Health Institute, Wireless Life Sciences Alliance and the QUALCOMM Wireless Health Group.

A global medical device technology leader of infusion systems, patient monitors and dedicated disposables. The business was acquired for $2.1B by Cardinal Health in May 2004.Developed strategy to leverage position in medical devices with an emerging position in information technology that enabled improvements in patient safety and clinical workflow.Architected and commercialized the first of its kind $350M portfolio for wireless Infusion Information System and patient safety client-server network, including enterprise connectivity and server and mobile side clinical applications. Strategic asset and premium contributor in Cardinal's deal valuation.

Entrepreneur, investor, and co-founder of iMetrikus. Responsible for operations and leading the commercialization of a new class (an industry first) of wireless health solutions for remote health monitoring and consumer empowerment for patients with chronic conditions. The company develops advanced e-health solutions aimed to lower the cost of care and improve patient access and compliance to care.

Executive Director of business unit within Chiron that developed web-based HIV disease management and informatics software, targeting commercial reference labs and physician networks, later sold to Bayer Diagnostics.

General Management and Operations, Corporate Development, and Marketing at Motorola’s healthcare division (EMTEK) concluding a successful merger with the Eclipsys Corporation (Allscripts: MDRX) in 1998.

Provided executive leadership in sales, marketing and international business development for ARKIVE, the industry leading Anesthesia Information System.

Founding member of the US team that built technical and marketing leadership in the anesthesia systems market space, growing business to $100M with 42% EBITDA. Globally recognized marketing and product architect for the Narkomed 3 Anesthesia System.